Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie (Q62031419)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie |
clinical trial |
Statements
A Double Blind, Randomized, Investigator Initiated Study on Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie (Lobeglitazone) in Patients With Type 2 Diabetes With Inadequate Control on Metformin and DPP-4 Inhibitor Therapy (English)
0 references
20 December 2018
0 references
31 December 2020
0 references
174
0 references
19 year
0 references
80 year
0 references